Heterogeneous IgE reactivities to Staphylococcus pseudintermedius strains in dogs with atopic dermatitis, and the identification of DM13-domain-containing protein as a bacterial IgE-reactive molecule.

Staphylococcus pseudintermedius DM13-domain-containing protein IgE atopic dermatitis dogs exacerbation factor

Journal

FEMS microbiology letters
ISSN: 1574-6968
Titre abrégé: FEMS Microbiol Lett
Pays: England
ID NLM: 7705721

Informations de publication

Date de publication:
26 02 2022
Historique:
received: 02 11 2021
revised: 25 01 2022
accepted: 18 02 2022
pubmed: 23 2 2022
medline: 5 3 2022
entrez: 22 2 2022
Statut: ppublish

Résumé

Staphylococcus pseudintermedius is one of the major pathogens causing canine skin infection. In canine atopic dermatitis (AD), heterogeneous strains of S. pseudintermedius reside on the affected skin site. Because an increase in specific IgE to this bacterium has been reported, S. pseudintermedius is likely to exacerbate the severity of canine AD. In this study, the IgE reactivities to various S. pseudintermedius strains and the IgE-reactive molecules of S. pseudintermedius were investigated. First, examining the IgE reactivities to eight strains of S. pseudintermedius using 141 sera of AD dogs, strain variation of S. pseudintermedius showed 10-63% of the IgE reactivities. This is different from the expected result based on the concept of Staphylococcus aureus clonality in AD patients. Moreover, according to the western blot analysis, there were more than four proteins reactive to IgE. Subsequently, the analysis of the common IgE-reactive protein at ∼15 kDa confirmed that the DM13-domain-containing protein was reactive in AD dogs, which is not coincident with any S. aureus IgE-reactive molecules. Considering these, S. pseudintermedius is likely to exacerbate AD severity in dogs, slightly different from the case of S. aureus in human AD.

Identifiants

pubmed: 35191469
pii: 6534253
doi: 10.1093/femsle/fnac019
pii:
doi:

Substances chimiques

Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of FEMS.

Auteurs

Iyo Takemura-Uchiyama (I)

Department of Bacteriology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Shikata-cho 2-5-1, Kita-ku Okayama-shi, Okayama 700-8558, Japan.
School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Hiroki Tsurui (H)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Hidekatsu Shimakura (H)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Tadahiro Nasukawa (T)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Ichiro Imanishi (I)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.
Kitasato University School of Medicine, Kitasato 1-15-1 Minami-ku Sagamihara-shi, Kanagawa 252-0373, Japan.

Jumpei Uchiyama (J)

Department of Bacteriology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Shikata-cho 2-5-1, Kita-ku Okayama-shi, Okayama 700-8558, Japan.
School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Tomoki Fukuyama (T)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Shuji Sakamoto (S)

Science Research Center, Kochi Medical School, Oko-cho 185-1 Kohasu Nankoku-shi, Kochi 783-8505, Japan.

Keiko Morisawa (K)

Science Research Center, Kochi Medical School, Oko-cho 185-1 Kohasu Nankoku-shi, Kochi 783-8505, Japan.

Masato Fujimura (M)

Fujimura Animal Hospital, Aomadanihigashi 5-10-26 Minoo-shi, Osaka 562-0022, Japan.

Hironobu Murakami (H)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Shuji Kanamaru (S)

Department of Life Science and Technology, Tokyo Institute of Technology, Nagatsuda-cho 4259, Midori-ku Yokohama-shi, Kanagawa 226-0026, Japan.

Kenji Kurokawa (K)

Faculty of Pharmaceutical Sciences, Nagasaki International University, Huistenbosch-cho 2825-7, Sasebo, Nagasaki 859-3298, Japan.

Keiko Kawamoto (K)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Keita Iyori (K)

Vet Derm Tokyo, Dermatological and Laboratory Service for Animals, 910 Shoubusawa, Fujisawa-shi, Kanagawa 252-0823, Japan.

Masahiro Sakaguchi (M)

School of Veterinary Medicine, Azabu University, Fuchinobe 1-17-71, Chuo-ku, Sagamihara-shi, Kanagawa 252-5201, Japan.
Institute of Tokyo Environmental Allergy, Hakusan 1-33-18, Bunkyo-ku, Tokyo 113-0001, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH